Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma with GEMCAP and mFOLFIRINOX Regimens: Adverse Events and Long-Term Outcomes. Voprosy onkologii, v. 72, n. 1, p. OF-2421, 11 Mar.2026.